Asano, Y.; Kashiwagi, S.; Goto, W.; Tanaka, S.; Morisaki, T.; Takashima, T.; Noda, S.; Onoda, N.; Ohsawa, M.; Hirakawa, K.;
et al. Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer. Cancers 2017, 9, 4.
https://doi.org/10.3390/cancers9010004
AMA Style
Asano Y, Kashiwagi S, Goto W, Tanaka S, Morisaki T, Takashima T, Noda S, Onoda N, Ohsawa M, Hirakawa K,
et al. Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer. Cancers. 2017; 9(1):4.
https://doi.org/10.3390/cancers9010004
Chicago/Turabian Style
Asano, Yuka, Shinichiro Kashiwagi, Wataru Goto, Sayaka Tanaka, Tamami Morisaki, Tsutomu Takashima, Satoru Noda, Naoyoshi Onoda, Masahiko Ohsawa, Kosei Hirakawa,
and et al. 2017. "Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer" Cancers 9, no. 1: 4.
https://doi.org/10.3390/cancers9010004
APA Style
Asano, Y., Kashiwagi, S., Goto, W., Tanaka, S., Morisaki, T., Takashima, T., Noda, S., Onoda, N., Ohsawa, M., Hirakawa, K., & Ohira, M.
(2017). Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer. Cancers, 9(1), 4.
https://doi.org/10.3390/cancers9010004